Summer travel (June through September) Summer is the highest-risk season for GLP-1 travel
Treatment not only suppressed the HFD-driven overexpression of lipogenic genes (e.g., Fasn , -22%
While these patient reports are anecdotal and more research is needed, they suggest that even modest doses could potentially influence how some people feel and function in their daily lives
Specifically, GIP agonism promotes lipolysis, while GCG agonism enhances substrate utilization and increases energy expenditure [9]
In adipose tissue, GIP cooperates with insulin to enhance glucose and lipid clearance in the fed state and boost lipolysis in the fasted state
The present study provides preliminary evidence in favor of the GLP-1 based therapies in providing beneficial effects against atherosclerosis as indicated by the significant reductions in atherosclerosis markers including BNP, PAI-1 and hsCRP, besides statistically non-significant reductions in several other markers including IMT, FMD, IL-6 and TNF- were also noted